$WAT News

RBC Capital Initiates Coverage of Waters (WAT) with Outperform Recommendation

Morgan Stanley Maintains Equal-Weight on Waters, Raises Price Target to $390

RBC Capital Initiates Coverage On Waters with Outperform Rating, Announces Price Target of $435

Guggenheim Reiterates Buy on Waters, Maintains $440 Price Target

Evercore ISI Group Maintains Outperform on Waters, Raises Price Target to $410

Waters Corp (NYSE:WAT) Shows Strong Growth and Technical Setup

Waters Corporation Schedules Second Quarter 2026 Earnings Conference Call

Bernstein Reinstates Outperform on Waters, Announces $435 Price Target

IMU Biosciences Selects Waters to Advance Breakthrough AI Immune Mapping Platform to Transform Early Diagnosis, Monitoring, and Precision Medicine

IMU Biosciences Selects Waters to Advance Breakthrough AI Immune Mapping Platform to Transform Early Diagnosis, Monitoring, and Precision Medicine

Waters Corporation (WAT): Buy, Sell, or Hold Post Q1 Earnings?

Waters Corp (NYSE:WAT) Technical Setup Signals High-Quality Breakout Opportunity

Waters Launches New Tools As Investors Weigh Biologics And Battery Upside

Piper Sandler Initiates Coverage of Waters (WAT) with Neutral Recommendation

Piper Sandler Initiates Coverage On Waters with Neutral Rating, Announces Price Target of $400

Waters Launches Coin Cell Differential Scanning Calorimeter (DSC) to Advance Battery Safety with Integrated Thermal, Evolved Gas, and Electrochemical Analysis

Waters Launches Industry-First Reversed-Phase Bioseparation Columns to Deliver Up to 3x Faster GLP-1 Characterization and 2x Faster LNP Component Analysis

Waters Launches Industry-First Reversed-Phase Bioseparation Columns to Deliver Up to 3x Faster GLP-1 Characterization and 2x Faster LNP Component Analysis

Why Is Waters (WAT) Up 8.7% Since Last Earnings Report?

Waters Corporation (WAT) Presents at Jefferies Global Healthcare Conference 2026 Transcript